Vaginal microbe-binding antibody interactions with a Lactobacillus crispatus live biotherapeutic following treatment for bacterial vaginosis
Microbiology Spectrum · 2026
DOI: 10.1128/spectrum.03983-25 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Rachel Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Toronto, Toronto, Canada. Hauptthemen laut MEDLINE: Antibodies, Bacterial, Lactobacillus crispatus, Probiotics, Vagina. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, CIHR, NIH HHS.
Abstract (Originalsprache)
The vaginal application of LACTIN-V, a live biotherapeutic containing Lactobacillus crispatus CTV-05, reduces the recurrence of bacterial vaginosis (BV) and promotes L. crispatus colonization; however, colonization success is variable. In 65 women with BV randomized to LACTIN-V or placebo following metronidazole treatment, we evaluated whether pre-existing or treatment-induced vaginal L. crispatus CTV-05-binding antibodies shaped colonization outcomes. CTV-05-binding IgA and IgG were commonly detected prior to BV treatment, with IgA predominating. Neither total nor CTV-05-binding IgA or IgG predicted colonization resistance; instead, baseline CTV-05-binding IgA was associated with colonization permissiveness. LACTIN-V application did not change overall vaginal antibody concentrations or induce CTV-05-binding IgA or IgG. Overall, L. crispatus CTV-05-binding IgA and IgG were common but are not a barrier to CTV-05 colonization, nor induced by LACTIN-V application. IMPORTANCE Recent clinical trials show that vaginal live biotherapeutics (therapeutic grade probiotics) containing the “optimal” vaginal species Lactobacillus crispatus have the potential to enhance vaginal health. However, application of these live biotherapeutics often does not lead to successful colonization of the vagina by L. crispatus . Prior studies have shown that the vagina often contains antibodies that bind L. crispatus , and we used samples from a clinical trial of the product Lactin-V to test the hypothesis that such antibodies may be induced by application and prevent colonization. Importantly, we confirmed that these antibodies were frequently found in the vagina of participants before application, but that they did not block (and may even have helped) colonization, and were not induced by the product. This is important information for the growing field of vaginal live biotherapeutics. CLINICAL TRIALS This study is registered with ClinicalTrials.gov as NCT02766023 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of Toronto, Toronto, Canada.
- Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.
- Department of Obstetrics, Gynecology & Reproductive Sciences, University of California, San Francisco, San Francisco, California, USA.
- Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California, USA.
- Osel, Mountain View, California, USA.
ORCID-Profile: Eric Armstrong, Steve Miller, Thomas P Parks, Bryan Coburn, Rupert Kaul
Förderung
- NIAID NIH HHS
- CIHR
- NIH HHS
- National Institutes of Health
- Canadian Institutes of Health Research
Zitieren
APA
Liu, R., Armstrong, E., Hemmerling, A., Miller, S., Huibner, S., Lagenaur, L., Parks, T. P., Cohen, C. R., Coburn, B., & Kaul, R. (2026). Vaginal microbe-binding antibody interactions with a Lactobacillus crispatus live biotherapeutic following treatment for bacterial vaginosis. Microbiology Spectrum. https://doi.org/10.1128/spectrum.03983-25
Vancouver
Liu R, Armstrong E, Hemmerling A, Miller S, Huibner S, Lagenaur L, et al. Vaginal microbe-binding antibody interactions with a Lactobacillus crispatus live biotherapeutic following treatment for bacterial vaginosis. Microbiology Spectrum. 2026. doi:10.1128/spectrum.03983-25
BibTeX
@article{Liu2026,
author = {Liu, Rachel and Armstrong, Eric and Hemmerling, Anke and Miller, Steve and Huibner, Sanja and Lagenaur, Laurel and Parks, Thomas P and Cohen, Craig R and Coburn, Bryan and Kaul, Rupert},
title = {Vaginal microbe-binding antibody interactions with a Lactobacillus crispatus live biotherapeutic following treatment for bacterial vaginosis},
journal = {Microbiology Spectrum},
year = {2026},
doi = {10.1128/spectrum.03983-25}
}
EUVIMED